Experts Look At How To Speed Approval Of Variant COVID-19 Vaccines
‘Global Forum’ Needed For Consensus On Requirements
Senior members of three key regulatory and health bodies this week gave their assessments of the protection that existing COVID-19 vaccines may offer against future strains of the virus, and the requirements for developing and assessing modified vaccines.
You may also be interested in...
Coronavirus Notebook: EMA Explains How To Get A Modified Vaccine Approved, UK Starts Oxford/AZ Variant Vaccine Trial
Draft legislation on strengthening the European Medicines Agency’s role in health crises has cleared another hurdle, and the European Commission is inviting companies to a matchmaking event aimed at scaling up the development and production of COVID-19 therapeutics.
The effectiveness of coronavirus vaccines in preventing infection and symptomatic COVID-19 disease was explored at a virtual meeting held by the European Medicines Agency.
The EU institutions are taking steps to preserve the effectiveness of existing vaccines in the face of mutations in the SARS-CoV-2 virus.